Post-Traumatic Stress Disorder (PTSD) research hub
3 indexed studies · 2 currently recruiting
- ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Pilot Study to Assess the Use of Methylone in the Treatment of PTSD IMPACT-1 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
This study, IMPACT-1, is looking into a new medication called Methylone for people with Post-Traumatic Stress Disorder (PTSD). It's an early-stage study to see if it's safe and how well it might work to reduce symptoms.
Ireland - not yet recruitingPHASE2
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
This study looks at how a specific treatment using psilocybin, given with a type of therapy called ACT, might help adults aged 18-65 who developed PTSD after experiencing domestic abuse. It aims to see if this treatment can reduce their PTSD symptoms.
Canada - not yet recruitingPHASE3
Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Placebo-controlled Trial to Investigate the Efficacy of Pediatric Prolonged-release Melatonin
This study looks into how a special type of melatonin medicine for children might help those aged 2-18 with PTSD who have trouble sleeping. It compares it to a dummy pill to see if it improves sleep, PTSD symptoms, and daily life for both the children and their families.
France